Precision Biosciences (DTIL) Selling, General & Administrative (2018 - 2026)
Precision Biosciences (DTIL) Selling, General & Administrative (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - | -10.08 Mn |
| 2 | Nanobiotix | 1,935.05 Bn | 1,934.98 Bn | - | - |
| 3 | Akari Therapeutics | 1,021.31 Bn | 1,021.31 Bn | - | 2.17 Mn |
| 4 | BeOne Medicines | 467.89 Bn | 463.10 Bn | 1.35 Bn | 555.10 Mn |
| 5 | Vertex Pharmaceuticals | 122.95 Bn | 115.70 Bn | 2.59 Bn | 493.70 Mn |
| 6 | Regeneron Pharmaceuticals | 70.19 Bn | 61.44 Bn | 3.31 Bn | 647.70 Mn |
| 7 | Belite Bio | 63.46 Bn | 63.46 Bn | - | 17.02 Mn |
| 8 | Argenx Se | 55.64 Bn | 50.45 Bn | 1.41 Bn | 1.13 Bn |
| 9 | Alnylam Pharmaceuticals | 37.67 Bn | 34.66 Bn | 959.66 Mn | 322.55 Mn |
| 10 | Precision Biosciences | 186.61 Mn | 158.31 Mn | - | 6.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.80 Mn |
| Dec 31, 2025 | 7.23 Mn |
| Sep 30, 2025 | 7.33 Mn |
| Jun 30, 2025 | 9.13 Mn |
| Mar 31, 2025 | 8.55 Mn |
| Dec 31, 2024 | 9.58 Mn |
| Sep 30, 2024 | 8.77 Mn |
| Jun 30, 2024 | 8.53 Mn |
| Mar 31, 2024 | 8.43 Mn |
| Dec 31, 2023 | 8.54 Mn |
| Sep 30, 2023 | 9.63 Mn |
| Jun 30, 2023 | 9.83 Mn |
| Mar 31, 2023 | 11.09 Mn |
| Dec 31, 2022 | 10.02 Mn |
| Sep 30, 2022 | 10.28 Mn |
| Jun 30, 2022 | 10.44 Mn |
| Mar 31, 2022 | 10.68 Mn |
| Dec 31, 2021 | 10.59 Mn |
| Sep 30, 2021 | 9.64 Mn |
| Jun 30, 2021 | 9.94 Mn |